These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9422008)

  • 21. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conducting research in individual patients: lessons learnt from two series of N-of-1 trials.
    Wegman AC; van der Windt DA; Stalman WA; de Vries TP
    BMC Fam Pract; 2006 Sep; 7():54. PubMed ID: 16984636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy preference and treatment outcome in clients with mild to moderate alcohol dependence.
    Adamson SJ; Sellman DJ; Dore GM
    Drug Alcohol Rev; 2005 May; 24(3):209-16. PubMed ID: 16096124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences and clinical trial design and interpretation: appreciation and critique of a paper by Feine, Awad & Lund.
    Bradley C
    Community Dent Oral Epidemiol; 1999 Apr; 27(2):85-8. PubMed ID: 10226717
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized controlled trials.
    Thompson MK
    Br J Gen Pract; 1991 Dec; 41(353):520. PubMed ID: 1807334
    [No Abstract]   [Full Text] [Related]  

  • 26. Rejoinder to Bradley: Patient preferences and clinical trial design and appreciation and critique of a paper by Feine, Awad & Lund.
    Feine JS; Awad MA; Lund JP
    Community Dent Oral Epidemiol; 1999 Apr; 27(2):89-92. PubMed ID: 10366290
    [No Abstract]   [Full Text] [Related]  

  • 27. [Analysis on the dependence and intention of experimental randomized controlled therapy].
    Liu JP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec; 23(12):884-6. PubMed ID: 14714353
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient preference and validity of randomized controlled trials.
    Torgerson D; Moffett JK
    JAMA; 2005 Jul; 294(1):41-2; author reply 42. PubMed ID: 15998886
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient preference and validity of randomized controlled trials.
    Cho AH; Jackson GL; Bosworth HB
    JAMA; 2005 Jul; 294(1):41; author reply 42. PubMed ID: 15998887
    [No Abstract]   [Full Text] [Related]  

  • 30. Understanding controlled trials. What is a patient preference trial?
    Torgerson DJ; Sibbald B
    BMJ; 1998 Jan; 316(7128):360. PubMed ID: 9487173
    [No Abstract]   [Full Text] [Related]  

  • 31. Can improved communication increase patient participation in randomised clinical trials?
    Sawka CA; Pritchard KI
    Eur J Cancer; 2001 Feb; 37(3):297-9. PubMed ID: 11239751
    [No Abstract]   [Full Text] [Related]  

  • 32. Patients' preferences and randomised trials.
    Thornton H
    Lancet; 1994 Sep; 344(8923):689. PubMed ID: 7915378
    [No Abstract]   [Full Text] [Related]  

  • 33. Patients' preferences and randomised trials.
    Finch E; Gossop M; Hankinson L; Taylor C; Farrell M; Strang J
    Lancet; 1994 Sep; 344(8923):688-9. PubMed ID: 7915377
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of randomised clinical trials.
    Frase W
    Eur J Clin Pharmacol; 2005 Mar; 61(1):63-4; author reply 65-6. PubMed ID: 15785962
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized clinical trials and patient preferences.
    Mangalik A; Neidhart J
    Ann Intern Med; 1992 Oct; 117(8):700. PubMed ID: 1530212
    [No Abstract]   [Full Text] [Related]  

  • 36. What is a randomised controlled trial?
    Cipriani A; Geddes JR
    Epidemiol Psichiatr Soc; 2009; 18(3):191-4. PubMed ID: 20034195
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient recruitment for clinical trials.
    Lichter PR
    Ophthalmology; 1991 Oct; 98(10):1489-90. PubMed ID: 1961631
    [No Abstract]   [Full Text] [Related]  

  • 38. Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial.
    Dell'Utri CM; Manzoni E; Bonfanti I; Marrocco F; Barbara G; Pifarotti P; Chiaffarino F
    Menopause; 2024 Sep; 31(9):801-808. PubMed ID: 38954491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "You can't always get what you want": from doctrine to practicability of study designs for clinical investigation in endometriosis.
    Vercellini P; Somigliana E; Cortinovis I; Bracco B; de Braud L; Dridi D; Milani S
    BMC Womens Health; 2015 Oct; 15():89. PubMed ID: 26490454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.